CLL-IPIInternational Prognostic Index for CLL
Demographics & Serology
years
mg/L
Cutoff: 3.5 mg/L
Genetics & Staging
Awaiting Data
The CLL-IPI integrates genetic, biochemical, and clinical markers to stratify newly diagnosed CLL.
Scoring Highlights
- TP53 aberration: 4 points
- IGHV unmutated: 2 points
- Beta-2M > 3.5 mg/L: 2 points
Guidelines & Evidence
Verified
Last Review: 2026
Last Comprehensive Review: 2026
